• Nanion Technologies: イオンチャネル研究のスマートツール

    Nanion Technologies: イオンチャネル研究のスマートツール

  • SyncroPatch 384i: HTS Automated Patch Clamp

    SyncroPatch 384i: HTS Automated Patch Clamp

  • SURFE²R 96SE: ラベルフリーのトランスポーターHTS

    SURFE²R 96SE: ラベルフリーのトランスポーターHTS

  • Dynamic Clamp: Patchliner

    Dynamic Clamp: Patchliner

  • 脂質二分子膜実験: Orbitシリーズ

    脂質二分子膜実験: Orbitシリーズ

  • CardioExcyte 96 SOL: 心筋の光ペーシング

    CardioExcyte 96 SOL: 心筋の光ペーシング

Our Product Portfolio

SyncroPatch 384i

SyncroPatch 384i

Patchliner

Patchliner

Port-a-Patch

Port-a-Patch

Port-a-Patch mini

Port-a-Patch mini

CardioExcyte 96

CardioExcyte 96

FLEXcyte 96

FLEXcyte 96

SURFE²R 96SE

SURFE²R 96SE

SURFE²R N1

SURFE²R N1

Orbit 16

Orbit 16

Orbit Mini

Orbit Mini

Vesicle Prep Pro

Vesicle Prep Pro

KV1.3 "Automated internal perfusion of Jurkat cells expressing KV1.3 channels"

icon pap   Port-a-Patch application note:   logo pdf   (0.2 MB) 

Summary:

KV1.3 is a voltage-gated potassium channel which plays a role in human T cell activation and proliferation, cell-mediated cytotoxicity and volume regulation. It is therefore an important target for the therapeutic control of T cell
responses. The KV1.3 channel is endogenously expressed in Jurkat cells, an immortalised T lymphocyte cell line. The channel is activated by membrane depolarisation at voltages typically more positive than -40 mV with rapid activation kinetics and slower inactivation. In common with many other voltage-gated potassium channels, KV1.3 can be blocked by replacing K+ with Cs+ ions in the pipette solution. Using Nanion’s Internal Perfusion System, we were able to record stable KV1.3 currents from Jurkat cells and reliably block this potassium current by perfusing the internal side of the chip with a Cs+-containing solution. The KV1.3 mediated current could also be completely recovered by perfusing the inside of the chip with K+-containing solution. KV1.3 mediated currents can also be blocked by internal perfusion with tetraethylammonium (TEA). We present data here showing block of KV1.3 by increasing concentrations
of TEA using the Internal Perfusion System. The IC50 that we obtained for TEA applied internally was in good agreement with the literature.

Back

We use cookies on our website. Some of them are essential for the operation of the site, while others help us to improve this site and the user experience (tracking cookies). You can decide for yourself whether you want to allow cookies or not. Please note that if you reject them, you may not be able to use all the functionalities of the site.